Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Revium Rx (RVRC) Operating Leases (2025 - 2026)

Updated

Revium Rx (RVRC) posted Operating Leases of $44,000 for Q2 2026.

Analysis

Revium Rx (RVRC) Operating Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Revium Rx's Operating Leases came in at $46,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Revium Rx 86.84 Mn 75.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44,000.00
Mar 31, 2026 67,000.00
Dec 31, 2025 46,000.00
API Access

Revium Rx Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RVRC&period=max&api_key=YOUR_API_KEY